Switch to:
More From Other Websites
Bristol-Myers Drug Combination Shows Promise Against Melanoma Apr 20 2015
Final Glance: Pharmaceuticals companies Apr 20 2015
Final Glance: Pharmaceuticals companies Apr 20 2015
Merck's Keytruda Tops Melanoma, Lung Cancer Studies - Analyst Blog Apr 20 2015
Bristol-Myers' Study on Opdivo Halted on Early Success - Analyst Blog Apr 20 2015
Bristol, Merck Cancer Drugs Strut Their Stuff Apr 20 2015
New data boosts biotechs Apr 20 2015
BRISTOL MYERS SQUIBB CO Files SEC form 8-K/A, Change in Directors or Principal Officers Apr 20 2015
Bristol-Myers combination melanoma treatment shows promise Apr 20 2015
Bristol-Myers: 2 cancer drugs beat 1 against melanoma Apr 20 2015
Bristol-Myers: 2 cancer drugs beat 1 against melanoma Apr 20 2015
Midday Glance: Pharmaceuticals companies Apr 20 2015
Midday Glance: Pharmaceuticals companies Apr 20 2015
Early Glance: Pharmaceuticals companies Apr 20 2015
Early Glance: Pharmaceuticals companies Apr 20 2015
Test May Show Merck Melanoma Drug’s Success in Lung Cancer Apr 20 2015
3 Big Pharmaceutical Stocks Will Have Rising Q1 Earnings Apr 20 2015
Immune System Drugs Melt Tumors In New Study, Leading A Cancer Revolution Apr 20 2015
First Randomized Study Evaluating Opdivo (nivolumab)+Yervoy (ipilimumab) Regimen Demonstrates... Apr 20 2015
8:31 am Bristol-Myers announces positive results from a Phase II trial, evaluating the Opdivo... Apr 20 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK